NFκB Signaling |
Induction of Jagged 1 expression in non-cancer stem cells |
Stimulation of Notch signaling in cancer stem cells |
Basal-like breast cancer cell lines |
21 |
|
Induction of PI3K/Akt pathway |
Activation of Notch1, tumor growth |
Human melanoma samples and cell lines |
23 |
Tissue Hypoxia |
Stabilization of HIF-1a |
Activation of Notch, tumor growth |
Human melanoma samples and cell lines |
23 |
|
Stabilization of Hif-1a |
Augmented Notch1 signaling, altered expression of cell cycle regulatory proteins, accelerated cell proliferation |
T-cell acute lymphoblastic leukemia cells |
24 |
|
Induction of Notch pathway, up-regulation of Notch ligand expression |
Induced EMT, E-Cadherin down-regulation, expression of Snail1 |
Cell lines of cervical, colon, glioma and ovarian cancer; breast cancer |
26, 27 |
|
Induction of 66-kDA isoform of the SHC gene (p66Shc) |
Induction of Notch3 signaling, self-renewal (induction of Jagged1) and hypoxia survival |
Mammospheres |
25 |
Epithelial to mesenchymal transition (EMT) |
Transforming growth factor-beta (TGF-b) induction |
Expression of Hey1 and Jagged1 |
Epithelial cells from mammary gland, kidney tubules and epidermis |
28 |
WNT |
β-catenin/TCF-mediated transcriptional activation of Jagged1 |
Activated Notch1 and Notch2 in tumors containing nuclear β-catenin |
Colorectal cancer cells, human tumors from FAP |
30 |